Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0

Int J Mol Sci. 2022 Jul 18;23(14):7894. doi: 10.3390/ijms23147894.

Authors

Mariapia Vairetti¹, Giuseppe Colucci², Andrea Ferrigno¹

Affiliations

¹ Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
² Division of Gastroenterology and Hepatology, Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, 20122 Milano, Italy.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is among the most common liver diseases worldwide, affecting up to 20-30% of the human population [...].

Publication types

Editorial

MeSH terms

Humans
Liver
Non-alcoholic Fatty Liver Disease* / drug therapy
Non-alcoholic Fatty Liver Disease* / epidemiology